Scott -
I know you aren't a Jansen Biotech employee or anything like that, but you should be well aware of the side-effect profile of these class of drugs. Having access to the best GIs in the world doesn't necessarily correlate to better care at all. It's not like the mayo clinic uses novel therapies that aren't offered elsewhere. A GI who is 5-minutes away from me will give me a simponi script
if I ask for it.
I've just stopped looking at the studies sponsored by AbbVie, Jansen, Shire or the other manufacturing companies because they sugar coat the data and minimize all side-effects, making the drug look safer than the placebo. It's worth investigating why so many doctors jump straight to biologics when safer options are available.
Yes, many do consider 6MP/Imuran safe simply because those class of drugs been in the market longer and have a better track record at the moment. I think time only time will tell how safe biologics are.
Looking at the cochrane reviews (a third party organization with no conflict of interests) of simponi (and other biologics), they unanimously conclude that it is associated with very severe side effects and a higher risk of infections that would otherwise be latent. I really don't like my chances on
this page.
Overall, in the short term biologics were associated with statistically significantly higher rates of serious infections, TB reactivation, total AEs and withdrawals due to AEs. Serious infections included opportunistic infections as well as bacterial infections in most studies. Some biologics had a statistically higher association with certain adverse outcomes compared with control, but there was no consistency across the outcomes so caution is needed in interpreting these results.For what it's worth, I asked a locum GI to me put on simponi around this time last year, prior to a surgical consult. My GI refused given my poor track record with remicade and humira and told me to try other experimental therapies.